Molecular markers and biological targeted therapies in metastatic colorectal cancer

expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.

E. Van Cutsem, M. Dicato, N. Arber, J. Berlin, A. Cervantes, F. Ciardiello, A. De Gramont, E. Diaz-Rubio, M. Ducreux, R. Geva, B. Glimelius, R. Glynne Jones, Axel F Grothey, T. Gruenberger, D. Haller, K. Haustermans, R. Labianca, H. J. Lenz, B. Minsky, B. Nordlinger & 8 others A. Ohtsu, N. Pavlidis, P. Rougier, W. Schmiegel, C. Van de Velde, H. J. Schmoll, A. Sobrero, J. Tabernero

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC.

Fingerprint

Biological Therapy
Gastrointestinal Neoplasms
Expert Testimony
Colorectal Neoplasms
Manuscripts
Biomarkers
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Molecular markers and biological targeted therapies in metastatic colorectal cancer : expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009. / Van Cutsem, E.; Dicato, M.; Arber, N.; Berlin, J.; Cervantes, A.; Ciardiello, F.; De Gramont, A.; Diaz-Rubio, E.; Ducreux, M.; Geva, R.; Glimelius, B.; Glynne Jones, R.; Grothey, Axel F; Gruenberger, T.; Haller, D.; Haustermans, K.; Labianca, R.; Lenz, H. J.; Minsky, B.; Nordlinger, B.; Ohtsu, A.; Pavlidis, N.; Rougier, P.; Schmiegel, W.; Van de Velde, C.; Schmoll, H. J.; Sobrero, A.; Tabernero, J.

In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 21 Suppl 6, 06.2010.

Research output: Contribution to journalArticle

Van Cutsem, E, Dicato, M, Arber, N, Berlin, J, Cervantes, A, Ciardiello, F, De Gramont, A, Diaz-Rubio, E, Ducreux, M, Geva, R, Glimelius, B, Glynne Jones, R, Grothey, AF, Gruenberger, T, Haller, D, Haustermans, K, Labianca, R, Lenz, HJ, Minsky, B, Nordlinger, B, Ohtsu, A, Pavlidis, N, Rougier, P, Schmiegel, W, Van de Velde, C, Schmoll, HJ, Sobrero, A & Tabernero, J 2010, 'Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.', Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 21 Suppl 6. https://doi.org/10.1093/annonc/mdq273
Van Cutsem, E. ; Dicato, M. ; Arber, N. ; Berlin, J. ; Cervantes, A. ; Ciardiello, F. ; De Gramont, A. ; Diaz-Rubio, E. ; Ducreux, M. ; Geva, R. ; Glimelius, B. ; Glynne Jones, R. ; Grothey, Axel F ; Gruenberger, T. ; Haller, D. ; Haustermans, K. ; Labianca, R. ; Lenz, H. J. ; Minsky, B. ; Nordlinger, B. ; Ohtsu, A. ; Pavlidis, N. ; Rougier, P. ; Schmiegel, W. ; Van de Velde, C. ; Schmoll, H. J. ; Sobrero, A. ; Tabernero, J. / Molecular markers and biological targeted therapies in metastatic colorectal cancer : expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009. In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2010 ; Vol. 21 Suppl 6.
@article{c663d27b3061484eaa90cfce7840389e,
title = "Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.",
abstract = "The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC.",
author = "{Van Cutsem}, E. and M. Dicato and N. Arber and J. Berlin and A. Cervantes and F. Ciardiello and {De Gramont}, A. and E. Diaz-Rubio and M. Ducreux and R. Geva and B. Glimelius and {Glynne Jones}, R. and Grothey, {Axel F} and T. Gruenberger and D. Haller and K. Haustermans and R. Labianca and Lenz, {H. J.} and B. Minsky and B. Nordlinger and A. Ohtsu and N. Pavlidis and P. Rougier and W. Schmiegel and {Van de Velde}, C. and Schmoll, {H. J.} and A. Sobrero and J. Tabernero",
year = "2010",
month = "6",
doi = "10.1093/annonc/mdq273",
language = "English (US)",
volume = "21 Suppl 6",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Molecular markers and biological targeted therapies in metastatic colorectal cancer

T2 - expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.

AU - Van Cutsem, E.

AU - Dicato, M.

AU - Arber, N.

AU - Berlin, J.

AU - Cervantes, A.

AU - Ciardiello, F.

AU - De Gramont, A.

AU - Diaz-Rubio, E.

AU - Ducreux, M.

AU - Geva, R.

AU - Glimelius, B.

AU - Glynne Jones, R.

AU - Grothey, Axel F

AU - Gruenberger, T.

AU - Haller, D.

AU - Haustermans, K.

AU - Labianca, R.

AU - Lenz, H. J.

AU - Minsky, B.

AU - Nordlinger, B.

AU - Ohtsu, A.

AU - Pavlidis, N.

AU - Rougier, P.

AU - Schmiegel, W.

AU - Van de Velde, C.

AU - Schmoll, H. J.

AU - Sobrero, A.

AU - Tabernero, J.

PY - 2010/6

Y1 - 2010/6

N2 - The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC.

AB - The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC.

UR - http://www.scopus.com/inward/record.url?scp=77956625930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956625930&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdq273

DO - 10.1093/annonc/mdq273

M3 - Article

VL - 21 Suppl 6

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -